Unlike tumor PD-L1 expression, which has shown predictive value for the efficacy of anti-PD-1 therapy in most studies (Table 1), PD-L1 expression on immune cells in the tumor microenvironment was more correlated with treatment response to anti-PD-L1 therapy (212, 236) (Table 2). Here, CD274 is linked to neoplasm.